Back to Results
First PageMeta Content
Vaccines / Influenza A virus subtype H5N1 / Epidemiology / AstraZeneca / Pandemics / Influenza vaccine / Flu pandemic vaccine / FluMist / AS03 / Influenza / Medicine / Health


Stat NDA Template Draft 2
Add to Reading List

Open Document

File Size: 637,92 KB

Share Result on Facebook

City

Dresden / /

Company

AEs / Influenza A (H5N1) Virus Monovalent Vaccine / Cadham Provincial Laboratory / ID Biomedical Corporation / Table 1 Study Design / Glaxosmithkline plc / /

Country

Indonesia / United States / Vietnam / Canada / /

Currency

SCR / /

Event

FDA Phase / /

IndustryTerm

treatment / sentinel site / /

MedicalCondition

H1N1 influenza / influenza-like illness / disease / onset chronic diseases / influenza A / pandemic influenza / disorders / both influenza A / /

MedicalTreatment

immunization / Active immunization / vaccination / /

Organization

Research office of Biostatistics / Biostatistics and Epidemiology Division / Food and Drug Administration Center for Biologics Evaluation / DEPARTMENT OF HEALTH AND HUMAN SERVICES / /

Person

Van Buynder / Lead Mathematical Statistician / Tsai-Lien Lin / Estelle Russek-Cohen / A. Dale Horne / Van Buynder Arepanrix / John Scott / Christopher Egelebo / Carmen M Collazo-Custodio / Andrea James / /

Position

Mathematical Statistician / physician / P.H. Chief / /

Product

H5N1 / AS03 / Pan-009 / PAN-001 / Pan-002 / Pan-010 / Pan-005 / /

ProvinceOrState

Quebec / New Brunswick / Manitoba / Hawaii / /

Technology

antibodies / /

SocialTag